XML 65 R65.htm IDEA: XBRL DOCUMENT v3.20.1
Note 14 - Stockholders' Equity (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Dec. 06, 2019
Dec. 24, 2018
Dec. 21, 2018
Apr. 04, 2018
Dec. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Common Stock, Shares, Issued, Total (in shares)         13,697,420 13,697,420 10,711,088
Proceeds from Issuance of Private Placement           $ 22,982,000 $ 32,893,000
The 2011 Long-term Incentive Plan [Member]              
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares)   1,400,000          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)         149,000 149,000 484,000
Series I Warrants Issued with Offering [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) 1,458,333            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) $ 12.09            
Warrants and Rights Outstanding, Term (Year) 5 years            
Common Stock Maximum Ownership Percentage For Warrant Exercise 4.99%            
Common Stock Maximum Ownership Percentage For Warrant Exercise, Per Each Holder 19.99%            
Conversion of Loan Payable as Part of Private Placement Financing [Member]              
Shares Issued, Price Per Share (in dollars per share)         $ 9.06 $ 9.06  
Debt Conversion, Original Debt, Amount $ 2,950,000       $ 2,950,000    
Private Placement [Member]              
Stock Issued During Period, Shares, New Issues (in shares) 2,916,666            
Shares Issued, Price Per Share (in dollars per share) $ 9.06            
Proceeds from Issuance of Common Stock $ 26,400,000            
Common Stock, Shares, Issued, Total (in shares)     3,928,513        
Share Price (in dollars per share)     $ 9.9396        
Proceeds from Issuance of Private Placement     $ 39,000,000        
Private Placement [Member] | Lee’s Pharmaceutical Holdings Limited [Member]              
Debt Conversion, Original Debt, Amount     6,000,000        
Private Placement [Member] | Battelle [Member]              
Debt Conversion, Original Debt, Amount     $ 1,000,000        
Private Placement [Member] | LPH II [Member]              
Stock Issued During Period, Shares, New Issues (in shares)       180,555      
Shares Issued, Price Per Share (in dollars per share)       $ 14.40      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)       45,139      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)       $ 16.56      
Warrants and Rights Outstanding, Term (Year)       7 years      
Private Placement, Purchase Price of Common Stock and Warrants       $ 2,600,000      
Class of Warrant or Right, Vesting Period (Month)       180 days      
Private Placement [Member] | Series F Warrants [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)     667,847        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)     $ 11.04        
Warrants and Rights Outstanding, Term (Year)     1 year 180 days        
Private Placement [Member] | Series G Warrants [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)     1,296,410        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)     $ 12.15        
Warrants and Rights Outstanding, Term (Year)     5 years        
Private Placement [Member] | December 2018 Warrants [Member]              
Common Stock Maximum Ownership Percentage For Warrant Exercise     9.99%